IntelGenx Technologies Corp.

Common Stock SEC Reporting - Current
OTCQX U.S. OTCQX Advisor: Dorsey & Whitney LLP
Contact Info
  • 6420 Abrams
  • St. Laurent, QC H4S 1Y2
  • Canada

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001098880
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1999
Employees 26 a/o Mar 01, 2016
Company Officers/Contacts
Horst G. Zerbe, Ph.D CEO, President
Ingrid Zerbe Corporate Secretary
Karen Kalajajian Controller
Company Directors
Horst G. Zerbe, Ph.D Chairman
J. Bernard Boudreau Vice Chairman
John Marinucci
Clemens Mayr
Bernd J. Melchers
Mark Nawacki
John Troup
Company Notes
  • Sponsored for OTCQX by Dorsey & Whitney LLP on 06/14/2012
Service Providers
OTCQX Advisor
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202

Accounting/Auditing Firm
Richter LLC.
1981 McGill College
Montreal, QC, H3A 0G6

Legal Counsel
Dorsey & Whitney LLP
TD Canada Trust Tower Brookfield Place
161 Bay Street
Suite 4310
Toronto, ONT, M5J 2S1

Investor Relations Firm
Not Available
IGXT Security Details
Share Structure
Market Value1 $49,459,396 a/o Nov 22, 2017
Authorized Shares 200,000,000 a/o May 11, 2017
Outstanding Shares 66,837,021 a/o Aug 09, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 54,797,920 a/o Jan 26, 2017
Par Value 0.00001
Shareholders of Record 46 a/o Jan 26, 2017
Short Selling Data
Short Interest 9,774 (3.61%)
Oct 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security